$CPB

Top analysts reset Campbell’s stock amid major challenges

Between June 1-5, five Wall Street analysts adjusted Campbell’s (CPB) outlook ahead of its June 8 Q3 fiscal 2026 results, according to Benzinga. Targets were cut by Morgan Stanley ($21 from $23), Bernstein ($19 from $21, downgraded to underperform), UBS ($19 from $20), and Evercore ISI ($24 from $26). Campbell reported adjusted EPS of 50 cents (+1 penny YoY, -32%), net sales down 4% to $2.4B, and margin pressure from tariffs; snacks margins fell ~400 bps.

Original reporting
Published Jun 11, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 12:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top analysts reset Campbell’s stock amid major challenges — source image
Decision brief

The 30-second read

$CPBBearishLow
01

Why it matters

The article links analyst target reductions to the June 8 earnings details: weaker net sales, contracting gross margin, and explicit tariff-driven cost pressure, with snacks identified as the weakest segment.

02

Market read

Traders should focus on whether snacks margins stabilize and whether tariff/input-cost inflation eases, since these are the concrete drivers cited for the analyst resets.

03

What to watch

Dividend yield is elevated (~7.3%) and management prioritizes debt reduction; if tariff costs absorb/decline faster than expected, the market may re-rate the stock despite near-term snacks weakness.

Relevance 7/10Novelty 4/10Timing: after June 8 earnings; analyst target resets reported June 1–5

Background

Campbell’s is typically treated as a defensive packaged-food name due to recession-resilient demand for soups and snacks.

Company-level read

Ticker impact

$CPBBearishMedium confidence
Context

Campbell’s earnings showed adjusted EPS down 32% and net sales down 4%, with tariffs adding 310 bps cost pressure.

Expected impact

Near-term downside/underperformance risk versus defensive peers until snacks margins stabilize and tariff inflation eases.

Evidence & confidence

The article ties multiple analyst target reductions to the June 8 earnings print, highlighting contracting gross margin (27.7%) and explicit tariff cost pressure (310 bps), plus management commentary on continued snacks margin pressure.

Market effects

Reinforces that even defensive food names can face margin compression from tariffs/input-cost inflation, shifting focus to segment-level profitability (snacks vs soups).

Primarily US demand and tariff/input-cost dynamics (U.S. soup consumption down 4.4%).

Tariff and supply-chain cost pressures are framed as persistent into next fiscal year, potentially affecting broader packaged-food cost structures.

Counterpoint

The company reaffirmed full-year fiscal 2026 guidance and premium Rao’s consumption grew 15%, suggesting some demand resilience that could limit downside if costs normalize.

Key entities

  • Campbell’s

    CPB; earnings showed declining sales and margins, with tariffs adding 310 bps cost pressure and snacks margins still under pressure.

Related articles

$UTZMed

Family-owned companies have big appetites for US snack M&A

Utz UTZ.N agreed to be taken private by Germany’s Intersnack Group, with Utz’s founding families, in a deal valued at nearly $3 billion, the first U.S. acquisition for Intersnack. The article cites other family-led snack deals including Ferrero’s purchases of WK Kellogg and Power Crunch, and Mars’s $36 billion take-private of Kellanova. It notes valuation multiples and potential targets.

$CPBMedAI 8/10

Campbell's Q3 Earnings Call Highlights

Campbell’s executives said incentive compensation reset and higher marketing are expected to add about a $40 million impact next year, while the company plans to accelerate savings from a previously announced $100 million SG&A reduction and other productivity initiatives. Snacks margins improved sequentially (EBITDA margin ~7% to ~10%) but remain ~400 bps below last year. Q4 net sales are expected flat to slightly up; adjusted EPS likely around $2.20 or below.

$MRVLMed

Index rebalancing can deliver bargains. Here’s how to find them

S&P 500 index managers announced quarterly changes: Marvell Technology and Flex Ltd. will join the index, while Pool Corp. and Campbell’s Co. will be removed. The article says added stocks have averaged about +255% over the past year versus -36% for deletions. It cites Research Affiliates’ 2024 paper: deletions outperformed by over 5% annually over the next five years.

$MUMed

ASX set to rise, Wall Street steadies as tech stocks rebound

Wall Street steadied after last week’s sell-off, with the S&P 500 up 0.3% (Nasdaq +0.9%, Dow -0.2%). AI-linked chip and memory stocks rebounded: Micron rose 9.9% after a 13.3% Friday drop; Marvell gained 9.6% after being approved for the S&P 500. ASX futures pointed to a 0.3% open gain. Oil rose on Israel-Iran strikes, with Brent settling at $94.25 (+1.2%).

$MUMed

ASX set to rise, Wall Street steadies as tech stocks rebound

Wall Street steadied after last week’s sell-off as AI-linked tech rebounded. The S&P 500 rose 0.3% (after a 2.6% Friday drop); Nasdaq gained 0.9%. ASX futures pointed to a 0.3% rise. Micron jumped 9.9% after a 13.3% Friday fall; Marvell rose 9.6% after S&P Dow Jones said it would join the S&P 500. Oil firmed on Israel-Iran strikes; Brent settled at $94.25 (+1.2%).